Beijing Beilu Pharmaceutical Co., Ltd (SZSE:300016) Signed a Letter of intent to acquire 80% stake in Chengde Tianyuan Pharmaceuticals Co.,Ltd from Goldenmax International Group Ltd. (SZSE:002636) for CNY 248 million on February 29, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.92 CNY | -0.86% | +17.89% | -22.33% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
6.92 CNY | -0.86% | +17.89% | 702M | ||
4.94 CNY | +1.23% | +13.30% | 332M | ||
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.33% | 702M | |
+75.75% | 2,160B | |
+33.22% | 633B | |
+17.95% | 620B | |
+9.06% | 259B | |
+15.67% | 189B | |
+4.41% | 163B | |
-38.85% | 133B | |
+34.43% | 127B | |
+35.90% | 106B |
- Stock Market
- Equities
- 002636 Stock
- News Goldenmax International Group Ltd.
- Beijing Beilu Pharmaceutical Co., Ltd Signed a Letter of intent to acquire 80% stake in Chengde Tianyuan Pharmaceuticals Co.,Ltd from Goldenmax International Group Ltd. for CNY 248 million.